NTLA
Intellia Therapeutics, Inc. · Healthcare
Director John F Crowley sold $299K of Intellia Therapeutics, Inc.
Sold$298,875
$119.55Price
2,500Shares
−54%Stake
What NTLA did after the filing
- The stock from Wed, Oct 13 close, $125.35
- −7.8%
- S&P 500, same days
- +7.9%
Measured over 30 trading days, to the Nov 24 close.
Traded Mon, Oct 11. Filed Wed, Oct 13, 12:15 PM ET, during the session. Returns use the Oct 13 close and the Nov 24 close. Not investment advice.